跳至主要内容
临床试验/NCT05751694
NCT05751694招募中不适用

Effectiveness of Visceral Manual Therapy in Bruxist Patients

University of Seville2 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
68
试验地点
2
主要终点
Pressure pain threshold (PPT) Baseline-1

研究概览

简要总结

Objective: check the effectiveness of visceral manual therapy on bruxist patients Design: Experimental, analytical, longitudinal, prospective, randomized, single-blind study with a blinded evaluator.

Subjects: 68 subjects over 18 years old, with bruxism (diagnoses by a dentist). Methods: Subjects will be randomized into 2 groups: an experimental group (EG) to which a visceral manual technique will be applied and a control group (CG) to which a placebo manual technique will be administered. Both groups will receive 2 interventions one week apart. The measurements will be made before and after the interventions, and a last measurement will be made one month after the last intervention. Therefore, the patient will visit the center 3 times.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with bruxism diagnosed and referred by a dentist
  • Age: older than 18 years-old.

排除标准

  • Recent craniofacial, mandibular or cervical trauma or fracture.
  • Temporomandibular joint surgery.
  • Acute pain due to other components of the masticatory system (caries, inflammation of the dental root).
  • Abdominal surgery.
  • Gastric ulcers.
  • Gastritis.
  • Previous or current gastric neoplasm.
  • Neurological or systemic diseases.
  • Pregnant, including the period of breastfeeding.
  • Patients receiving chemotherapy or radiotherapy.
  • Cognitive, psychosomatic or psychiatric illnesses that may affect the data obtained.
  • Basic systemic disease of rheumatic origin (for example, arthritis, osteoarthritis, gout and psoriasis).
  • Cerebrovascular and brain diseases.
  • Arrhythmia and other cardiac problems.
  • Implanted electronic devices.
  • Drug or alcohol abuse, analgesic or sedative therapy, and use of medications that affect the central nervous system (for example, antidepressants, anxiolytics, and anticonvulsants).
  • Patients who have previous experience with manual treatment of the diaphragm

结局指标

主要结局

Pressure pain threshold (PPT) Baseline-1

时间窗: Baseline pre-intervention

The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

PPT Change-1

时间窗: Change from "PTT Baseline-1" immediately post-intervention

The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

PPT Baseline-2

时间窗: Baseline pre-intervention at 7 days

The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

PPT Change-2

时间窗: Change from "PTT Baseline-2" immediately post-intervention

The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

PPT Change-3

时间窗: Change from "PTT Baseline-2" and "PTT Change-2" at 1 month

The pressure pain threshold of the fourth cervical vertebra and masseter and temporal muscles will be evaluated using the Wagner Force TenTM Digital Force Gage model FPX 100 algometer. 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

Heart Rate Variability (HRV) Baseline-1

时间窗: Baseline pre-intervention

Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

HRV Change-1

时间窗: Change from "HRV baseline-1" inmediately post-intervention

Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

HRV Baseline-2

时间窗: Baseline pre-intervention at 7 days

Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

HRV Change-2

时间窗: Change from "HRV baseline-2" inmediately post-intervention

Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

HRV Change-3

时间窗: Change from "HRV baseline-2" and "HRV change-2" at 1 month

Heart rate variability (HRV) was measured using a Polar H10 strap and the EliteHRV mobile app to collect the data. These data were exported to Kubios software to obtain HRV results. A 5-minute measurement was performed with the patient in the supine position.

Myotonometry baseline-1

时间窗: Baseline pre-intervention

The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

Myotonometry change-1

时间窗: Change from "myotonometry baseline-1" inmediately post-intervention

The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

Myotonometry baseline-2

时间窗: Baseline pre-intervention at 7 days

The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

Myotonometry change-2

时间窗: Change from "myotonometry baseline-2" inmediately post-intervention

The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

Myotonometry change-3

时间窗: Change from "myotonometry baseline-2" and "myotonometry change-2" at 1 month

The muscle tone of the masseter muscle was assessed using a myotonometer (Myoton muscle diagnostics). 3 measurements will be made with a period of 30 seconds between measurements and we will obtain the average of the 3.

次要结局

  • Cervical Range of Motion (CROM) Baseline-1(Baseline pre-intervention)
  • Cervical Range of Motion (CROM) Change-1(Change from "CROM Baseline-1" immediately post-intervention)
  • Cervical Range of Motion (CROM) Baseline-2(Baseline pre-intervention at 7 days)
  • Cervical Range of Motion (CROM) Change-2(Change from "CROM Baseline-2" immediately post-intervention)
  • Cervical Range of Motion (CROM) Change-3(Change from "CROM Baseline-2" and "CROM Change-2" at 1 month)
  • Perceived Stress Scale (PSS-14) Baseline(Baseline)
  • PSS-14 Change(Change from Baseline PSS-14 at 1 month)
  • Mandibular Mobility Baseline-1(Baseline pre-intervention)
  • Mandibular Mobility Change-1(Change from "Mandibular Mobility Baseline-1" immediately post-intervention)
  • Mandibular Mobility Baseline-2(Baseline pre-intervention at 7 days)
  • Mandibular Mobility Change-2(Change from "Mandibular Mobility Baseline-2" immediately post-intervention)
  • Mandibular Mobility Change-3(Change from "Mandibular Mobility Baseline-2" and "Mandibular Mobility Change-2" at 1 month)
  • Pittsburgh Sleep Quality Index (PSQI) Baseline(Baseline)
  • PSQI Change(Change from Baseline PSQI at 1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lourdes María Fernández Seguín

Assistant Professor. Physiotherapy Department

University of Seville

研究点 (2)

Loading locations...

相似试验